Schumacher Electric Corporation Launches Rugged Lithium Ion Jump Starter
3.11.2021 11:03:00 EET | Business Wire | Press release
Schumacher Electric Corporation, the global leader of automotive aftermarket power conversion products, has introduced its new Rugged Lithium Ion Jump Starter series to the United States and European markets. Available in 1000, 1500, 2000 and 2500 peak amps, these jump starters are powerful, portable and compact, and can safely start a dead battery in seconds. The line will be available online and in select retailers.
“Our national lithium jump starter launch times perfectly for winterization preparations as the jump starters feature pre-heating technology to warm batteries in extreme cold,” said Mickey Leech, CEO at Schumacher Electric Corporation. “It’s also the perfect holiday gift for all drivers in your family or simply the person who has it all because of its multi-use design that includes the ability to charge a variety of USB devices. As we move towards our 75th company anniversary in 2022, we will continue to bring new, innovative products to market and set Schumacher apart from its competitors.”
Key features of the Schumacher Rugged Lithium Ion Jump Starter Product Line:
Schumacher 1000 Peak Amp Rugged Lithium Ion Jump Starter
- 1000 peak amps
- 25 jump starts per charge
- 4-cell, high-performance lithium technology
- Compatible with 6.0L gas and 3.0L diesel engines
- Each rugged cable is 36” in length for a total reach of over 6’
- Seven times lighter weight (than AGM batteries)
- Six times longer shelf life (than AGM batteries)
- Recharging is three times faster via powered USB port
- 2.4A USB charges devices twice as fast
- LED area light
Schumacher 1500 Peak Amp Rugged Lithium Ion Jump Starter
- 1500 peak amps
- 35 jump starts per charge
- 4-cell, high-performance lithium technology
- Compatible with 8.0L gas and 6.0L diesel engines
- Each rugged cable is 36” in length for a total reach of over 6’
- Seven times lighter weight (than AGM batteries)
- Six times longer shelf life (than AGM batteries)
- Recharging is three times faster via powered USB port
- 2.4A USB charges devices twice as fast
- LED area light
Schumacher 2000 Peak Amp Rugged Lithium Ion Jump Starter
- 2000 peak amps
- 45 jump starts per charge
- 4-cell, high-performance lithium technology
- Compatible with 10.0L gas and 8.0L diesel engines
- Each rugged cable is 36” in length for a total reach of over 6’
- Seven times lighter weight (than AGM batteries)
- Six times longer shelf life (than AGM batteries)
- Recharging is three times faster via powered USB port
- 2.4A USB charges devices twice as fast
- LED area light
Schumacher 2500 Peak Amp Rugged Lithium Ion Jump Starter
- 2500 peak amps
- 50 jump starts per charge
- 4-cell, high-performance lithium technology
- Compatible with 10.0L gas and 8.0L diesel engines
- Each rugged cable is 36” in length for a total reach of over 6’
- Seven times lighter weight (than AGM batteries)
- Six times longer shelf life (than AGM batteries)
- Recharging is three times faster
- 2.4A USB charges devices twice as fast via powered USB port
- LED area light
“We are pleased to bring top-of-the-line lithium jump starter products to market that are not only powerful but designed with ease-of-use in mind,” said Dirk Kuyckx, general manager of Schumacher Europe. “We wanted to offer a variety of products with unique features to meet the needs of all consumers and standout in a crowded market. Whether it’s a car, van, SUV, boat or recreational vehicle, our lithium jump starter has a durable rugged design with pre-boost technology for bringing even deeply discharged batteries back to life.”
About Schumacher Electric Corporation
Schumacher Electric Corporation is known for industry-leading innovation, an unwavering commitment to quality, and providing feature-rich products that represent a remarkable value and price. For nearly 75 years, Schumacher has been powering lifestyles with a legacy centered on delivering product excellence and exceptional service to customers with a broad range of needs and experience levels. Put your trust in a Schumacher.
To learn more visit: www.schumacherelectric.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211103005155/en/
Contact information
Chelsi Smith
Pierpont Communications
956-358-3300 (C)
csmith@piercom.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Rigaku and Tohoku University Establish a New Research Institute for X-Ray Metrology28.8.2026 17:00:00 EEST | Press release
Rigaku Corporation, a group company of Rigaku Holdings and a global solutions partner for X-ray analytical systems (Head Office: Akishima, Tokyo; President and CEO: Jun Kawakami; “Rigaku”), and Tohoku University (Sendai, Miyagi; President: Teiji Tominaga; “Tohoku University”) have established the Rigaku-Tohoku University Co-Creation Research Institute for X-ray Metrology: Beyond The Limits (the “Institute”) at Tohoku University on August 1, 2026. The Institute will advance X-ray metrology technology, develop new metrology methods, and foster the next generation of researchers through an initial three-year collaboration, with the possibility of extension based on its achievements. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828688510/en/ Inside the Institute As semiconductors become smaller, more multilayered, and incorporate a wider range of materials, manufacturing processes are becoming increasingly complex. X-ray me
BLK: Portfolio Company of Enry’s Island S.p.A., Lists on Euronext Dublin28.8.2026 16:34:00 EEST | Press release
Enry’s Island S.p.A. (WBAG:EIOS), an international venture builder with headquarters in the Tremiti Islands and the Metaverse, announces that BLK Global PLC, one of the portfolio companies within its ecosystem, has successfully completed its admission to trading on Euronext Access Dublin. Trading in the company’s shares commenced on Friday, July 31, 2026, under ticker BLKX and ISIN GB00BPSKS130. BLK was one of the thousands of applications received by Enry’s Island which, following an assessment process based on the Enry’s Model, was selected for a one-year incubation and acceleration programme. The programme supported the company through its subsequent growth stages, ultimately leading to its current stock market listing. Alessandro Pacciana, Investor Relations Manager of Enry’s Island S.p.A., said: “BLK’s listing is the second stock market listing in two years among Enry’s Island’s portfolio companies, while Enry’s Island itself is the world’s first listed venture builder. We are pro
Zambon Announces European Commission Approval of Hopledo® for Adults with Parkinson's Disease and Moderate to Severe Motor Fluctuations28.8.2026 12:00:00 EEST | Press release
Zambon today announced that the European Commission (EC) has granted marketing authorization for Hopledo® (modified-release levodopa/carbidopa) for the treatment of adult patients with Parkinson’s disease and moderate to severe motor fluctuations who have not been sufficiently stabilized with oral levodopa/dopa decarboxylase (DDC) inhibitor-based treatment regimens. Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026. The company is working closely with healthcare authorities and other stakeholders to support timely access for people with Parkinson’s disease who continue to experience moderate to severe motor fluctuations despite current oral therapies. Hopledo® is a first-in-class, oral, modified-release formulation of levodopa/carbidopa (LD/CD) approved for the treatment of motor fluctuations of Parkinson’s disease, the fastest growing neurological condition in the world according to the World Health Organization1. Despite availab
MTG-I2 Safely in Orbit, Unlocking Faster and Sharper Weather Monitoring Across Europe28.8.2026 11:16:00 EEST | Press release
The Meteosat Third Generation Imager 2 satellite (MTG-I2) has successfully passed its first critical post-launch milestones, completing the first full Meteosat Third Generation constellation in orbit. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828243790/en/ Credit: Arianespace livestream The imager satellite MTG-I2 is safely in orbit and operating as expected following its successful launch yesterday at 22:11 CEST on board an Ariane 6 rocket from Europe’s Spaceport in French Guiana. Our teams have established communication with the spacecraft, which has also deployed its solar panels to ensure its autonomous production of energy. MTG-I2 is in perfect shape to start its Launch and Early Operations Phase that will bring it to a higher orbit, 36 000km above Earth over the following two weeks, where a longer period of calibration and validation of its instruments will begin. This summer’s extreme weather and wildfires hav
New Daiichi Sankyo Data Underscore the Effect of Bempedoic Acid in the Real-World Management of Dyslipidemia and Cardiovascular risk28.8.2026 11:00:00 EEST | Press release
Daiichi Sankyo (TSE:4568) today announced new results from the MILOS study that demonstrate the real-world impact of bempedoic acid administered either alone or as a fixed-dose combination with ezetimibe, in the management of dyslipidaemia. Presented at the European Society of Cardiology Congress 2026 in Munich, the findings show that the clinically relevant reductions in low-density lipoprotein cholesterol (LDL-C) achieved within the first year of treatment are estimated to translate into clinically meaningful reductions in 10-year cardiovascular (CV) risk.1 The data further reinforce the clinical value of bempedoic acid, and its fixed-dose combination with ezetimibe, across a diverse range of patient subtypes, regardless of gender and glycaemic profile (diabetes, pre-diabetes, or normoglycemia).2,3 Key findings from the new analyses of the MILOS study include: 10-year CV risk estimate reduction: An analysis of 960 at-risk patients estimated that one year of bempedoic acid-add-on ther
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom